No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr2:55095200-55148200 |
Weak transcription |
Primary B cells from peripheral blood |
blood
|
2 |
chr2:55127000-55132400 |
Weak transcription |
Fetal Brain Male |
brain
|
3 |
chr2:55127600-55133400 |
Weak transcription |
Fetal Brain Female |
brain
|
4 |
chr2:55127800-55133400 |
Weak transcription |
Brain Substantia Nigra |
brain
|
5 |
chr2:55127800-55133600 |
Weak transcription |
Brain Inferior Temporal Lobe |
brain
|
6 |
chr2:55128000-55133400 |
Weak transcription |
Brain Angular Gyrus |
brain
|
7 |
chr2:55128000-55133400 |
Weak transcription |
Brain Dorsolateral Prefrontal Cortex |
brain
|
8 |
chr2:55128000-55133800 |
Weak transcription |
Brain Anterior Caudate |
brain
|
9 |
chr2:55129200-55133600 |
Weak transcription |
Brain Hippocampus Middle |
brain
|
10 |
chr2:55130200-55133800 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
11 |
chr2:55130400-55133800 |
Enhancers |
Fetal Intestine Large |
intestine
|
12 |
chr2:55130600-55131800 |
Flanking Active TSS |
A549 |
lung
|
13 |
chr2:55130600-55131800 |
Enhancers |
Monocytes-CD14+_RO01746 |
blood
|
14 |
chr2:55130600-55132200 |
Enhancers |
HSMMtube |
muscle
|
15 |
chr2:55130600-55132200 |
Enhancers |
HUVEC |
blood vessel
|
16 |
chr2:55130600-55133200 |
Enhancers |
NHLF |
lung
|
17 |
chr2:55130800-55131800 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
18 |
chr2:55130800-55131800 |
Flanking Active TSS |
Hela-S3 |
cervix
|
19 |
chr2:55130800-55132000 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
20 |
chr2:55130800-55132000 |
Enhancers |
Primary Natural Killer cells fromperipheralblood |
blood
|
21 |
chr2:55130800-55132000 |
Enhancers |
K562 |
blood
|
22 |
chr2:55130800-55132400 |
Flanking Active TSS |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
23 |
chr2:55130800-55132400 |
Enhancers |
Adipose Nuclei |
Adipose
|
24 |
chr2:55130800-55132400 |
Flanking Active TSS |
NHEK |
skin
|
25 |
chr2:55130800-55133600 |
Enhancers |
Fetal Intestine Small |
intestine
|
26 |
chr2:55131000-55131800 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
27 |
chr2:55131000-55131800 |
Enhancers |
Skeletal Muscle Female |
skeletal muscle
|
28 |
chr2:55131000-55132000 |
Flanking Active TSS |
Rectal Mucosa Donor 31 |
rectum
|
29 |
chr2:55131000-55132000 |
Enhancers |
Sigmoid Colon |
Sigmoid Colon
|
30 |
chr2:55131000-55132200 |
Enhancers |
Stomach Mucosa |
stomach
|
31 |
chr2:55131000-55133000 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
32 |
chr2:55131000-55134200 |
Enhancers |
Fetal Muscle Leg |
muscle
|
33 |
chr2:55131200-55131800 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
34 |
chr2:55131200-55131800 |
Enhancers |
HSMM |
muscle
|
35 |
chr2:55131200-55132000 |
Flanking Active TSS |
Liver |
Liver
|
36 |
chr2:55131200-55132200 |
Enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
37 |
chr2:55131200-55132200 |
Enhancers |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
38 |
chr2:55131200-55132200 |
Enhancers |
NH-A |
brain
|
39 |
chr2:55131200-55132400 |
Enhancers |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
40 |
chr2:55131400-55131800 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
41 |
chr2:55131400-55131800 |
Flanking Active TSS |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
42 |
chr2:55131400-55131800 |
Enhancers |
Primary T killer memory cells from peripheral blood |
blood
|
43 |
chr2:55131400-55131800 |
Flanking Active TSS |
Muscle Satellite Cultured Cells |
--
|
44 |
chr2:55131400-55131800 |
Enhancers |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
45 |
chr2:55131400-55132000 |
Enhancers |
Fetal Thymus |
thymus
|
46 |
chr2:55131400-55132000 |
Enhancers |
Pancreas |
Pancrea
|
47 |
chr2:55131400-55132000 |
Enhancers |
Psoas Muscle |
Psoas
|
48 |
chr2:55131400-55132000 |
Flanking Active TSS |
NHDF-Ad |
bronchial
|
49 |
chr2:55131400-55132000 |
Flanking Active TSS |
Osteobl |
bone
|
50 |
chr2:55131400-55132400 |
Flanking Active TSS |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|